Effects of dialysates on acidosis-related factors (EPO resistance, insulin resistance, and coronary calcification)in HD patients

Not Applicable

Recruiting

• Conditions: Chronic kidney disease stage 5D

• Registration Number: JPRN-UMIN000035085
• Lead Sponsor: Shonan Fujisawa Tokushukai Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-11-30
• Study Completion: 2023-03-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients with arrhythmia or inability to hold their breath 2) Pregnant or lactating patients 3) Patients with severe liver disease (Child-Pugh score: 10 or more points) 4)Patients with anemia due to active bleeding 5)Diabetes patients treated with insulin 6)History of hospitalization for treatment within 12 weeks 7)Fever, or elevated CRP value (over the upper limit of institutional reference value) 8)Ejection fraction =<25%] 9) Patients after coronary artery angioplasty and stenting 10) Patients scheduled for coronary artery intervention or coronary artery bypass 11) Patients taking warfarin 12) Patients scheduled for parathyroidectomy or percutaneous ethanol injection therapy (PEIT). 13) Patients who received other study drugs or investigational drugs within 12 weeks 14) Patients judged unsuitable as research subjects

Study & Design

• Study Type: Interventional
• Study Design: Not specified